Beth Israel Med. Ctr., ACTU

New York, New York 10003

0 studies enrolling now · 31 studies all time

What they study most

Cognition Disorders, Cytomegalovirus Infections, HIV Infections, Hepatitis B, Hepatitis C, Lipoatrophy, Lipodystrophy, Liver Disease, Peripheral Nervous System Diseases, Pregnancy, Wasting Disease

Studies at this site

• Effectiveness of and Immune Response to HIV Vaccination Followed by Treatment Interruption in HIV Infected Patients — Completed
• Pegylated Interferon Alfa-2a Maintenance Therapy and Liver Disease Progression in People Infected With Both HIV and Hepatitis C Virus (HCV) — Completed
• Cyclosporine A in Combination With Abacavir Sulfate, Lamivudine, and Zidovudine and Lopinavir/Ritonavir in HIV — Completed
• Effects of a Uridine Supplement on HIV Infected Adults With Lipoatrophy — Completed
• Safety and Effectiveness of Adding Either an HIV Vaccine, Interleukin-2, or Both to a Patient's Anti-HIV Drug Combination — Completed
• A Comparison of the Effectiveness, Safety, and Tolerability of Two Different Hepatitis C Treatments in Patients Infected With Both HIV and Hepatitis C Virus (HCV) — Completed
• Vaccine (ALVAC-HIV vCP1452) Use and Intermittent Withdrawal of Anti-HIV Drugs in Patients With HIV — Completed
• Safety and Effectiveness of the Selegiline "Patch" for Decreased Mental Function in HIV Patients — Completed
• Effect of Interleukin-2 on HIV Treatment Interruption — Completed
• Safety/Immunogenicity of Immunizations of ALVAC-DC-SC vs ALVAC-SC — Completed
• Using Drug Levels and Drug Resistance Testing to Select Effective Anti-HIV Drug Combinations in Patients With Drug-resistant HIV — Completed
• A Comparison of Adefovir and Tenofovir for the Treatment of Lamivudine-Resistant Hepatitis B Virus in People With HIV — Completed
• Effectiveness of Giving an HIV Vaccine (Remune) to HIV-Positive Patients Receiving an Anti-HIV Drug Combination — Completed
• A Study of HIV-Disease Development in Aging — Completed
• Preventing Cytomegalovirus (CMV) Organ Damage With Valganciclovir in People With HIV — Completed
• Comparing the Safety, Effectiveness, and Tolerability of Three Anti-HIV Drug Regimens for Treatment-Naive Patients — Completed
• Administration of Growth Hormone to Increase CD4+ Count in Patients Taking Anti-HIV Drugs — Completed
• Safety and Effectiveness of the Oral HIV Entry Inhibitor Vicriviroc in HIV Infected Patients — Completed
• Effect of an Intrauterine Contraceptive Device (IUD) in HIV Infected Women — Completed
• Drug Interactions Between Lopinavir/Ritonavir and Oral or Patch Contraceptives in HIV Infected Women — Completed
• Immune Response to a Therapeutic HIV Vaccine Followed by Treatment Interruption in Patients With Acute or Recent HIV Infection — Completed
• A Study to Compare Anti-HIV Drugs Given Twice a Day or Once a Day, With or Without Direct Observation — Completed
• A Study of DAPD Alone Versus DAPD Plus MMF for Treatment of HIV Infection — Completed
• Effects of Therapeutic HIV Vaccination on Control of HIV After Discontinuation of Anti-HIV Drugs — Completed
• Acetyl-L-Carnitine for the Treatment of NRTI-Associated Peripheral Neuropathy — Completed
• A Study of the Safety and Effectiveness of Hydroxyurea in Patients on Potent Antiretroviral Therapy and Who Have Less Than 200 Copies/ml of HIV RNA in Their Blood — Completed
• Five-Drug Anti-HIV Treatment Followed by Treatment Interruption in Patients Who Have Recently Been Infected With HIV — Completed
• Differences in Blood Levels of Lopinavir/Ritonavir in HIV Infected Men and Women — Completed
• Effects of Treatment Changes on Fat Wasting in the Arms and Legs of HIV Patients — Completed
• Addition of Efavirenz or Nelfinavir to a Lamivudine/Zidovudine/Indinavir HIV Treatment Regimen — Completed
• Comparison of Three Different Initial Treatments Without Protease Inhibitors for HIV Infection — Completed